ConductScience.org, home

Paper · 200722

Immunobiology of primary intracranial tumors. Part 3: Microcytotoxicity assays of specific immune responses of brain tumor patients.

Woosley RE and 4 others. J Neurosurg, 1977. Cited by 45 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immunobiology of primary intracranial tumors. Part 3: Microcytotoxicity assays of specific immune responses of brain tumor patients. Papers, record 200722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/200722

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunobiology of primary intracranial tumors. Part 3: Microcytotoxicity assays of specific immune responses of brain tumor patients.
PubMed
Journal
J Neurosurg
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
45
iCite
Relative citation ratio, by iCite
1.42
iCite
Revised in PubMed
2006-11-15
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Woosley RER E
2Mahaley MS JrM S
3Mahaley JLJ L
4Miller GMG M
5Brooks WHW H

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
Cytotoxicity, ImmunologicMajor topic
GliomaMajor topic
Adolescent
Adult
Aged
Cytotoxicity Tests, Immunologic
Female
Glioblastoma
Humans
Male
Meningioma
Middle Aged
Neurilemmoma

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 45 citations.

PMIDTitleJournalYearIn PapersSource
6,986,786Immunobiologic aspects of the brain and human gliomas. A review.Am J Pathol1980https://conductscience.org/library/papers/6986786PubMed
6,837,274Electron-microscopic visualization of binding of antibodies from sera of glioma patients on cultured glioma cells.Acta Neuropathol1983https://conductscience.org/library/papers/6837274PubMed
6,603,261Serial immune testing in surgically resected lung cancer patients.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6603261PubMed
6,352,007Serial immune function testing to predict clinical disease relapse in patients with solid tumors.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6352007PubMed
6,215,833Mechanisms by which human gliomas may escape cellular immune attack.Acta Neurochir (Wien)1982https://conductscience.org/library/papers/6215833PubMed
6,090,602Intratumoral autologous mononuclear cells in the treatment of recurrent glioblastoma multiforme. A phase 1 (toxicity) study.J Neurooncol1984https://conductscience.org/library/papers/6090602PubMed
3,497,030T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta.EMBO J1987https://conductscience.org/library/papers/3497030PubMed
3,258,871Immunocytochemical study of the cellular immune response in meningiomas.J Clin Pathol1988https://conductscience.org/library/papers/3258871PubMed
2,702,675Treatment of glioma with intratumoral instillation of autologous lymphocytes.Childs Nerv Syst1989https://conductscience.org/library/papers/2702675PubMed
676,675Tumor specific fluorescent and complement-dependent cytotoxic antibodies in the serum of rats with chemically induced brain gliomas.Acta Neuropathol1978https://conductscience.org/library/papers/676675PubMed

1 to 10 of 11

See all 11 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/200722

GET https://conductscience.org/api/papers/v1/200722/authors